Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Controlled Trial on Silodosin Versus Tamsulosin for Medical Expulsive Treatment of Ureteral Stones Size 5-10mm in Chinese

NCT05570084 is registered in ClinicalTrials.gov with Princess Margaret Hospital, Hong Kong as lead sponsor.

NCT NCT05570084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05570084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Controlled Trial on Silodosin Versus Tamsulosin for Medical Expulsive Treatment of Ureteral Stones Size 5-10mm in Chinese
Lead sponsor
Princess Margaret Hospital, Hong Kong
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2022
Completion date
December 31, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stone, urinary